Table 2 shows the demographics, clinical, and molecular characteristics of all patients with MM with (n = 55) and a subset of patients without (n = 169) APC/CTNNB1 genetic aberrations. This evidence concerns the gene CTNNB1 and Miyoshi myopathy.